FINWIRES · TerminalLIVE
FINWIRES

$PCRX

11 stories mentioning PCRXUpdated 41d ago

Every FINWIRES story that references PCRX, newest first.

Sectors

Sector Update: Healthcare

Healthcare stocks were edging higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) advancing by 0.4%.Pacira BioSciences' (PCRX) non-opioid pain therapy Exparel is now separately reimbursed by UnitedHealthcare (UNH) across outpatient settings, including hospital outpatient departments and ambulatory surgery centers, the company said. Shares of Pacira BioSciences were up more than 3% pre-bell.

$PCRX$UNH
Wire

Pacira BioSciences' Exparel Now Separately Reimbursed by UnitedHealthcare Across Outpatient Settings

Pacira BioSciences' (PCRX) non-opioid pain therapy Exparel is now separately reimbursed by UnitedHealthcare (UNH) across outpatient settings, including hospital outpatient departments and ambulatory surgery centers, the company said Wednesday.The update allows for Exparel to be reimbursed outside the surgical bundle for eligible UnitedHealthcare members, the company said.Shares of the company were up 1.3% in recent premarket trading.

$PCRX$UNH
Asia Markets

Update: S&P 500, Nasdaq Composite Close Strongest Quarter in Six Years Amid Gains in Technology, Decline in Crude Oil

(Updates with index/price moves, macroeconomic data, and company/geopolitical news from the first paragraph.)US equity indexes rose, with the S&P 500 and the Nasdaq Composite clocking the biggest quarterly advances since Q2 2020 amid semiconductor-led gains in technology and declining crude oil prices.The Nasdaq Composite jumped 1.5% to 26,213.72, and the S&P 500 rose 0.8% to 7,499.36 on Tuesday, June 30. The Dow Jones Industrial Average advanced 0.3% to 52,319.20, capping the strongest first half in five years.Technology was the standout gainer at the close, followed by industrials. Real estate, consumer staples, and utilities led the decliners. Technology is also the top sector over the past three months, according to data compiled by Finviz.Of the top 20 stocks with a market capitalization of more than $200 billion, 17 were from the tech sector, according to data compiled by Finviz. Within those tech names, the majority were either semiconductors or semiconductor equipment and materials. The top gainer was SanDisk (SNDK), trading up 11%.In geopolitical news, US envoy Steve Witkoff and President Donald Trump's son-in-law Jared Kushner are in Doha for meetings with Qatari mediators, according to CNN. Technical talks are ongoing, but there are currently no high-level meetings between the US and Iran, CNN reported, citing Qatar's Foreign Ministry spokesperson.Iran's Parliament Speaker Ghalibaf said the country will not begin negotiations for a final agreement before the implementation of clauses 1, 4, 5, 10, and 11 of the memorandum of understanding signed with the US earlier this month, Al Jazeera reported. These clauses involve cessation of hostilities in Lebanon, removal of the US naval blockade, safe passage of commercial vessels, waivers for the export of Iranian crude oil, and the release of frozen Iranian funds.The front-month global benchmark North Sea Brent slipped 0.3% to $72.92 per barrel, and the US West Texas Intermediate fell 1% to $70.07 per barrel. Both crude types traded above $110 a barrel at the height of the US-Iran war.Most US Treasury yields rose, with the 10-year jumping 7.3 basis points to 4.45%. The two-year rate climbed 4.9 basis points to 4.16%.Gold futures edged 0.2%% lower to $4,031.7, while silver futures dropped 2.3% to $59.52.In economic news, US job openings rose to 7.594 million in May, according to the Bureau of Labor Statistics, above the 7.296 million openings expected in a Bloomberg-compiled survey and up from the 7.585 million openings reported in April.The Conference Board's measure of consumer confidence rose to 91.2 in June from a downwardly revised 90.6 in May, below the 94.4 expected in a Bloomberg-compiled poll.The Institute for Supply Management's Chicago PMI fell to 56.7 in June from 62.7 in May, compared with the expected 55.1 reading in a Bloomberg-compiled survey.In company news, Air Products and Chemicals (APD) said it is finalizing an agreement for renewable ammonia from a green hydrogen project in Saudi Arabia. Shares of Air Products jumped 8%, among the top gainers on the S&P 500.Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Zimmer shares dropped 5.6%, among the worst performers on the S&P 500.

Dow JonesNasdaq CompositeS&P 500$APD$PCRX$SNDK
Sectors

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.9% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 1.1%.The iShares Biotechnology ETF (IBB) rose 0.2%.In corporate news, Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Pacira shares rose 1%, and Zimmer fell past 6%.Unicycive Therapeutics (UNCY) shares tumbled 40% after it said Tuesday it has received a Complete Response Letter from the US Food and Drug Administration over its resubmitted new drug application for oxylanthanum carbonate for treating hyperphosphatemia in people with chronic kidney disease on dialysis.AbbVie (ABBV) and Merck (MRK) are facing investigations by the China Select Committee of the US House over whether clinical trials conducted in China may have contributed to the country's military capabilities, Reuters reported. AbbVie shares were down 1.3%, and Merck shed nearly 1%.Align Technology (ALGN) shares fell 3% after the European Commission said Tuesday it has opened an antitrust probe to determine whether the company has violated EU competition rules by tying its dental clear aligners to its intra-oral scanners in the European Economic Area.

$ABBV$ALGN$MRK$PCRX$UNCY$ZBH
Sectors

Sector Update: Healthcare

Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.9%.The iShares Biotechnology ETF (IBB) rose 0.2%.In corporate news, Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Pacira shares rose 1%, and Zimmer fell past 6%.

$PCRX$ZBH
Wire

Top Midday Decliners

Unicycive Therapeutics (UNCY) said Tuesday it has received a Complete Response Letter from the US Food and Drug Administration over its resubmitted new drug application for oxylanthanum carbonate for treating hyperphosphatemia in patients with chronic kidney disease on dialysis.The letter relates to deficiencies previously identified at third-party manufacturing vendor, the firm said, adding that the FDA inspection of third-party facility did not occur during the resubmission review.Shares sank 37% amid a surge in intraday trading volume to over 17.2 million from a daily average of about 907,000 shares.JPMorgan Chase (JPM), which is running a stock and note offering from Sable Offshore (SOC), has seen limited investor demand for a loan paying 15%, Bloomberg reported Tuesday, citing people familiar with the matter.Sable shares sank 46% as intraday trading volume catapulted to over 45.0 million from a daily average of about 3.8 million.Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million.Zimmer shares dropped 7.5%, with intraday trading volume of over 2.31 million against a daily average of about 2.34 million.Price: $4.83, Change: $-2.87, Percent Change: -37.27%

$JPM$PCRX$SOC$UNCY$ZBH
Asia Markets

Update: US Equity Indexes Rise as Semiconductors Lift Technology; Crude Oil Slips as Trump's Envoys in Qatar for Indirect Talks

(Updates with index/price moves, macroeconomic data, and company news from the first paragraph.)US equity indexes rose, with the S&P 500 and the Nasdaq Composite set to clock the biggest quarterly gains since Q2 of 2020 amid semiconductor-led gains in technology.The Nasdaq Composite jumped 1.3% to 26,154.1, and the S&P 500 rose 0.7% to 7,490.7 after midday Tuesday. The Dow Jones Industrial Average advanced 0.3% to 52,348.4, heading for the strongest first half in five years.Technology was the standout gainer intraday, followed by industrials. Real estate, consumer staples, and healthcare led the decliners.Of the top 20 stocks with a market capitalization of more than $200 billion, 17 were from the tech sector, according to data compiled by Finviz. Within those tech names, the majority were either semiconductors or semiconductor equipment and materials. The top gainer was Advanced Micro Devices (AMD), trading up 7.7%.Bernstein adjusted the price target for SanDisk (SNDK) shares to $3,000 from $1,700 while maintaining its outperform rating. Shares of SanDisk were up 7.6%, one of the S&P 500 and Nasdaq's top gainers.In geopolitical news, US envoy for the Middle East Steve Witkoff and President Donald Trump's son-in-law Jared Kushner are in Doha to meet Qatari mediators, CNN reported Tuesday, citing Qatar's Foreign Ministry spokesperson. The US duo will not meet with Iranian officials, the report said.The mediators are working as go-betweens for US-Iran talks, which won't include any high-level officials, Qatar's Foreign Ministry spokesman Majed al-Ansari said, according to an Associated Press report.The front-month global benchmark North Sea Brent slipped 1.1% to $73.12 per barrel, and the US West Texas Intermediate fell 1.3% to $69.84 per barrel.Most US Treasury yields rose, with the 10-year up 3.6 basis points to 4.41%. The two-year rate climbed 2.2 basis points to 4.13%.Gold futures edged up 0.1%% to $4,040.5, and silver futures jumped 2.7% to $59.77.In economic news, US job openings rose to 7.594 million in May, according to the Bureau of Labor Statistics, above the 7.296 million openings expected in a Bloomberg-compiled survey and up from the 7.585 million openings reported in April.The Conference Board's measure of consumer confidence rose to 91.2 in June from a downwardly revised 90.6 in May, below the 94.4 expected in a Bloomberg-compiled poll.The Institute for Supply Management's Chicago PMI fell to 56.7 in June from 62.7 in May, compared with the expected 55.1 reading in a Bloomberg-compiled survey.In company news, Air Products and Chemicals (APD) said Tuesday it will not proceed with the Louisiana Clean Energy Project because the expected financial returns do not meet stringent return criteria. The company also said it's finalizing a marketing and distribution agreement with Yara International for renewable ammonia from a green hydrogen project in Saudi Arabia. Shares of Air Products jumped more than 8%, the top gainer on the S&P 500.Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Zimmer shares dropped 7.4%, the worst performer on the S&P 500.

Dow JonesNasdaq CompositeS&P 500$AMD$APD$PCRX$SNDK$ZBH
Sectors

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

Healthcare stocks were edging higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.2% higher and the iShares Biotechnology ETF (IBB) up 0.4%.Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Pacira BioSciences shares were up more than 3% and Zimmer Biomet stock declined by more than 1% pre-bell.Arcutis Biotherapeutics (ARQT) shares were up more than 1% after the company said the US Food and Drug Administration cleared an expanded use of its Zoryve cream to treat plaque psoriasis in children as young as 2 years old.Evotec (EVO) has expanded its Just-Evotec Biologics services with J.TRAIN, a new offering that lets biopharmaceutical companies use Evotec's manufacturing technology within their own facilities on a turnkey basis, the company said. Evotec shares were up more than 1% pre-bell.

$ARQT$EVO$IBB$PCRX$XLV$ZBH
Sectors

Sector Update: Healthcare

Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) up 0.1%.Pacira Biosciences (PCRX) has agreed to sell its Iovera cold-therapy pain relief system to Zimmer Biomet (ZBH) for up to $140 million. Pacira BioSciences shares were up more than 3% and Zimmer Biomet stock declined by more than 2% pre-bell.

$PCRX$ZBH
Wire

Pacira BioSciences Says Exparel Linked to Lower Opioid Use, Healthcare Costs

Pacira BioSciences (PCRX) said Wednesday that a real-world study evaluating Exparel injectable suspension in total shoulder arthroplasty patients showed lower opioid consumption, reduced healthcare costs, and fewer opioid-related adverse events.The study analyzed data from July 2019 to December 2024 from more than 6,400 opioid-naive Medicare Advantage patients undergoing outpatient total shoulder arthroplasty and compared outcomes between those given Exparel and those who received standard-of-care analgesia, the company said.Exparel, or bupivacaine liposome, is approved in the US for postsurgical pain management, the company said.Price: $24.43, Change: $+0.07, Percent Change: +0.27%

$PCRX
Wire

RBC Raises Price Target on Pacira Biosciences to $24 From $22, Keeps Sector Perform Rating

Pacira Biosciences (PCRX) has an average rating of overweight and mean price target of $29.29 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $25.39, Change: $-0.10, Percent Change: -0.39%

$PCRX

Track with the FINWIRES app suite